CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.12% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money

Trade PROCEPT BioRobotics Corp - PRCT CFD

69.61
8.43%
Market Trading Hours* (UTC) Opens on Wednesday at 14:30

Mon - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.11
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.023346 %
Charges from full value of position ($-4.44)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.023346%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.001124 %
Charges from full value of position ($0.21)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.001124%
Overnight fee time 22:00 (UTC)
Min traded quantity 0.1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 76.02
Open 76.03
1-Year Change 67.43%
Day's Range 68.43 - 76.03
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jan 21, 2025 69.61 -6.62 -8.68% 76.23 76.23 68.40
Jan 17, 2025 75.91 -3.03 -3.84% 78.94 79.16 75.68
Jan 16, 2025 78.73 2.70 3.55% 76.03 79.11 75.95
Jan 15, 2025 78.20 -5.43 -6.49% 83.63 83.68 77.95
Jan 14, 2025 81.70 -2.25 -2.68% 83.95 84.26 79.60
Jan 13, 2025 82.82 -1.43 -1.70% 84.25 84.26 80.40
Jan 10, 2025 86.62 3.37 4.05% 83.25 87.20 83.25
Jan 8, 2025 86.31 -0.21 -0.24% 86.52 86.96 84.46
Jan 7, 2025 87.43 -1.22 -1.38% 88.65 89.15 85.36
Jan 6, 2025 88.52 4.14 4.91% 84.38 89.27 84.37
Jan 3, 2025 84.20 0.92 1.10% 83.28 85.27 83.11
Jan 2, 2025 83.02 2.06 2.54% 80.96 84.13 80.96
Dec 31, 2024 80.47 -0.48 -0.59% 80.95 82.31 79.95
Dec 30, 2024 80.88 0.48 0.60% 80.40 81.98 79.50
Dec 27, 2024 81.95 -0.95 -1.15% 82.90 83.10 81.04
Dec 26, 2024 83.46 0.97 1.18% 82.49 85.24 82.49
Dec 24, 2024 83.39 2.94 3.65% 80.45 83.71 80.29
Dec 23, 2024 80.98 -0.09 -0.11% 81.07 81.37 79.78
Dec 20, 2024 81.20 2.24 2.84% 78.96 82.16 78.96
Dec 19, 2024 80.62 -1.47 -1.79% 82.09 83.48 79.22

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

PROCEPT BioRobotics Corporation Company profile

About Procept Biorobotics Corp

Procept Biorobotics Corporation is a commercial-stage surgical robotics company. The Company is focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia (BPH). Its AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. It designs Aquablation therapy to deliver outcomes for males suffering from lower urinary tract symptoms (LUTS), due to BPH that are independent of prostate size and shape or surgeon experience.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Procept Biorobotics Corp revenues increased from $7.7M to $34.5M. Net loss increased 13% to $59.9M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Interest expense increase of 10% to $5.8M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$1.25 to -$1.38.

Industry: Medical Equipment, Supplies & Distribution (NEC)

900 Island Drive
Suite 210
REDWOOD CITY
CALIFORNIA 94065
US

People also watch

US100

21,736.00 Price
+0.480% 1D Chg, %
Long position overnight fee -0.0233%
Short position overnight fee 0.0011%
Overnight fee time 22:00 (UTC)
Spread 1.8

Gold

2,761.55 Price
+0.580% 1D Chg, %
Long position overnight fee 0.0110%
Short position overnight fee -0.0193%
Overnight fee time 22:00 (UTC)
Spread 0.30

BTC/USD

104,920.30 Price
-1.880% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

XRP/USD

3.16 Price
-1.040% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 0.01578

Still looking for a broker you can trust?

Join the 680,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading